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ABSTRACT 
Background: The increasing global trends in obesity and its associated burden of disease 
indicate a need to identify modifiable determinants of obesity. 
Methods: A total of 182 nutrition and lifestyles factors were investigated in relation to 
abdominal obesity among 7,403 male and 8,328 female participants of the Third U.S. 
National Health and Examination Survey (NHANES III). We used the first phase (1988-
1991) of the NHANES III to identify factors with a false discovery rate (FDR) of <5%. Of 
these, we tentatively replicated our findings in the second phase (1992-1994) of the survey. 
Principal component analysis was performed to identify unobserved factors underlying the 
association between validated factors and abdominal obesity, defined as waist circumference 
>88 cm for women and >102 cm for men.  
Results: We found 5 tentatively replicated factors showing significant associations with 
abdominal obesity in men: serum α-carotene, -carotene, serum -cryptoxanthin, serum 
vitamin D, and vigorous physical activity. In women, 7 factors were identified: serum α-
carotene, -carotene, serum -cryptoxanthin, serum vitamin C, serum vitamin D, vigorous 
physical activity, and aspartame intake. In contrast to the other factors which showed inverse 
associations with abdominal obesity, aspartame intake displayed a positive relationship with 
this outcome (OR: 1.18, 95% CI: 1.10-1.26 for each log increase in aspartame intake in 
women). Principal component analysis suggested three principal components underlying such 
associations, each comprising: 1) serum antioxidants; 2) serum vitamin D and vigorous 
physical activity; and 3) aspartame intake. All three principal components also displayed 
significant associations with abdominal obesity. 
Conclusion: Our observational investigation that systematically investigates multiple 
modifiable factors simultaneously has enabled the creation of data-driven hypotheses 
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regarding the possible role of determinants of abdominal obesity and has identified potential 
avenues for mechanistic investigations to clarify suitable targets of intervention. 
Introduction 
The obesity pandemic remains a challenging health problem worldwide [1], with 
approximately 2.1 billion individuals estimated to be overweight or obese in 2013. Although 
some countries have shown indications of rate stabilisation during the past decade, the 
prevalence of obesity continues to increase in both developed and developing regions [1–3]. 
High body mass index (BMI), a widely accepted indicator of obesity, is a well-known risk 
factor for diseases with serious implications including cardiovascular disease and several 
cancers [4,5], and accounted for over 33 million disability-adjusted life years (DALYs) lost 
in 2000 [6]. Moreover, obesity-related diseases confer a large economic burden, with an 
estimated rise in total medical costs of $48–66 billion/year in the U.S. and £1.9–2 billion/year 
in the UK by 2030 [7]. Nevertheless, outcomes of public health strategies aimed at reducing 
obesity rates are unsatisfactory. Although interventions based on reduction in energy intake 
lead to weight loss, the lengthy period required for an obese individual to reach their normal 
weight implies limited efficiency [8], which indicates that policies should be directed towards 
obesity prevention rather than its reversal. 
 
Identification of suitable targets of obesity prevention requires an understanding of at least 
two key concepts: 1) clinically relevant definition of obesity and 2) factors involved in 
mechanisms underlying obesity. Although obesity is conventionally defined by high BMI, the 
Third Report of Adult Treatment Panel (ATP III) of the National Cholesterol Education 
Program refers to waist circumference as the recommended measurement since abdominal 
obesity is closely related to metabolic disorders such as abnormal lipid profile, glucose 
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tolerance, and blood pressure [9]. Nevertheless, heterogeneity in other metabolic features has 
been reported within the same obesity categories [10], which underlines the importance of 
taking into account variation in metabolic indicators in assessing determinants of obesity. 
 
Although around 40% of obesity cases are considered heritable [11,12], environmental 
factors such as energy intake and physical activity remain the major driving forces underlying 
obesity [13]. Additionally, environmental factors may indirectly contribute to obesity through 
interaction with susceptibility genes [14]. Many studies have documented correlations 
between these factors and obesity, but most of them focused on individual associations 
without their co-existence, which is in contrast with a real life situation. Recently, Patel and 
colleagues introduced an environment-wide association study approach derived from 
methods used in genome-wide association studies (GWAS) to investigate the association of 
multiple nutrition and environmental factors with clinical phenotypes including blood 
pressure, diabetes, and mortality [15–17]. Here, we utilised this approach to comprehensively 
assess nutrition and lifestyle factors in relation to abdominal obesity in the Third U.S. 
Nutrition Health and Examination Survey (NHANES III). Additionally, we took into account 
other metabolic disorders and unobserved underlying factors while assessing abdominal 
obesity. 
Methods 
Study population 
The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional 
health survey conducted by the National Center for Health Statistics (NCHS) in 
representative samples of the non-institutionalized U.S. population [18]. Participants were 
selected through a multistage stratified, clustered probability sampling. The survey included 
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an interview conducted at home and an extensive physical examination with a blood sample 
taken in a mobile examination center (MEC). Institutional Review Board (IRB) approval was 
obtained for the NHANES and documented consent was obtained from participants. The 
present study was based on data from the Third NHANES (NHANES III) which was 
performed in two phases: 1988-1991 and 1991-1994, each of which provides independent 
unbiased national estimates of health and nutrition characteristics. From this population, we 
selected a total of 15,721 participants (7,403 men and 8,328 women) aged 20 and older with 
measurements of waist circumference. The first phase of NHANES III (N = 7,743) was used 
as a discovery set and findings from this dataset were replicated in the second phase of 
NHANES III (N = 7,988). 
Obesity assessment 
Abdominal obesity referred to waist circumference (WC) of >88 cm in women and >92 cm in 
men as defined by the experts in the Adult Treatment Panel (ATP) under the National 
Cholesterol Education Program (NCEP) [9]. All body measurements were performed using 
standardized methods and equipment [18]. WC was measured at the high point of the iliac 
crest at minimal respiration using a steel measuring tape to the nearest 1 mm [18]. Waist-to-
hip ratio was calculated from WC and hip circumference. Body mass index (BMI) was 
calculated from measured weight and height. Weight was measured with an electronic weight 
scale in pounds and automatically converted to kilograms. Participants only wore underwear, 
disposable paper gowns and foam rubber slippers. Standing height was measured with a fixed 
stadiometer to the nearest 1 mm.  
Assessment of exposures and covariates 
A total of 182 nutrition and lifestyle factors in NHANES III were assessed (Table S1, 
Supplementary Data). Data collected ranged from information obtained through the 
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interview, such as smoking history, as well as physical and laboratory examination, e.g. 
serum vitamin C concentrations. Examples of markers and categories are presented in Table 
1. Excluding reproductive-related factors such as external hormone use, 176 factors were 
equally assessed in both men and women. These factors were assessed either as continuous or 
categorical variables. The majority of continuous variables had a right-skewed distribution. 
We transformed these variables into standardised z-scores by subtracting the mean and 
dividing by the standard deviation (SD) of the population. For categorical variables, we 
consistently defined one value as the referent category or the “negative” result, e.g. “never 
smoker” as the reference for “current smoker”. Vigorous physical activity (yes, no) was 
defined as participating three or more times per week in leisure-time physical activities with 
metabolic equivalent (MET) ≥6 for those aged 60 and older, and MET ≥7 for those younger 
than 60 [19]. Secondary exposure to smoking among never smokers (never smoked ≥100 
cigarettes) was defined as exposure to smoke at home (≥1 person smoke at home) or at work 
(≥1 hours smoke exposure at work). All exposure variables were assessed with standard 
procedures as detailed in the NHANES III documentation [18,20].  
 
The following variables have been suggested to strongly affect environmental factors and 
obesity and were therefore considered as confounders in our study: age, sex, race/ethnicity, 
education and socioeconomic status (SES). Race/ethnicity was categorised into Non-Hispanic 
white, Non-Hispanic black, Mexican-American, and other. We classified educational 
attainment as less than high school, high school equivalent, and higher than high school. SES 
was estimated with poverty-to-income ratio (PIR), a ratio of total family income to the 
official poverty threshold at the family level. A PIR <1 indicated that income was less than 
the level of poverty. We categorised PIR into <1, 1-<2, 2-<3, and ≥3, indicating lowest to 
highest SES as previously described [21]. 
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The ATP-III definition of metabolic syndrome apart from waist circumference was used to 
define presence of other metabolic disorders [9]. Hypertension was defined by blood pressure 
of ≥130/≥85 mmHg or any use of antihypertensive drugs. Diabetes was defined as fasting 
glucose ≥110 mg/dL or any use of insulin or glucose-lowering drugs. Any HDL-cholesterol 
levels <40 mg/dL for men or <50 mg/dL for women were considered as low. 
Triglyceridaemia was defined as any levels of triglycerides ≥150 mg/dL. Blood pressure was 
measured with mercury manometer and the average of the second and third blood pressure 
measurements was taken. Fasting plasma glucose levels were measured by using a modified 
hexokinase enzymatic method (Roche Diagnostic Systems, Inc., Montclair, NJ). Blood lipids 
were enzymatically measured using the Hitachi 704 Analyzer (Boehringer Mannheim 
Diagnostics, Indianapolis, IN) [18].  
Statistical analysis 
Sampling weights specific to each phase were included in all analyses. Fig 1 summarises the 
analytical steps in this study which were similar to previously published nutrient- and 
environment-wide studies [15,16,22,23]. WC was used as an outcome instead of BMI, and 
was assessed as a dichotomous instead of a continuous outcome given that this definition of 
abdominal obesity has been widely accepted to be clinically relevant to risk of diabetes and 
cardiovascular disease [24]. We selected factors corresponding to categories of 
environmental exposures used in a previous EWAS study as summarised in Table 1 [16].  
First, each of the 182 nutrition and lifestyle factors was assessed in relation to abdominal 
obesity in the discovery set, phase I of the NHANES III. Survey-weighted logistic regression 
was used to examine the association of continuous and dichotomous nutrition and lifestyle 
factors in men and women separately. All models were linearly adjusted for age, 
race/ethnicity, education and PIR by adding each term into the regression model.  
©    2016 Macmillan Publishers Limited. All rights reserved.
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Next, we estimated the false discovery rate (FDR) among findings in the discovery set. FDR 
is the expected proportion of false discoveries, among all significant findings at a given 
significance level [25]. Using a significance level α of 0.05, we estimated FDR using the 
Benjamini-Hochberg step down method [26] to select factors with statistically significant 
association with obesity status and FDR<5% in the discovery set. A sensitivity analysis was 
performed by selecting all factors with FDR<1%. Because physical activity and smoking 
status classifications were derived from other variables, we performed a sensitivity analysis 
including the four categories of physical activity (vigorous, moderate, light physical activity, 
and sedentary) [19] instead of using it dichotomously. Similarly, for smoking status we 
repeated our analyses by only including the main smoking categorisation (current, former and 
never smokers) [27] and continuous levels of serum cotinine, the primary metabolite of 
nicotine [28], as indicators of smoking exposures. 
 
Replicated analysis of assessed nutrition and lifestyle factors was subsequently performed by 
re-running similar logistic regression models in the second dataset, namely phase II of 
NHANES III (Fig 1). Only nutrition or lifestyle factors with both FDR <5% in the first 
dataset and p value <0.05 in the replication set were considered valid. Furthermore, analysis 
for replicated factors in the overall study population was repeated in additional multivariable 
models adjusting for other metabolic disorders (i.e., hypertension, diabetes, low HDL, and 
hypertriglyceridaemia) and models incorporating all replicated factors. To account for 
potential effects of body type differences, a sensitivity analysis was performed by a further 
adjustment for BMI or waist-to-hip ratio as a continuous variable. 
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Finally, our secondary aim was to understand any underlying factors associated with 
abdominal obesity based on inter-correlation among tentatively replicated nutrition and 
lifestyle factors in the overall study population. For this purpose, we performed a principal 
component analysis with an orthogonal varimax rotation procedure. An eigenvalue of >1 was 
used to define the number of principal components to be extracted from our data [29]. 
Proportion of variance in abdominal obesity explained by each principal component was 
estimated, and 95% confidence intervals of this estimation were obtained using 1000 
bootstrap resampling [30]. We further estimated the value of principal components identified 
and assessed them in relation to abdominal obesity using similar multivariable approach. 
McFadden R
2 
values were computed to estimate variance explained by the model, and the 
variance explained only by replicated nutrition and lifestyle factors or principal components. 
 
The NHANES III datasets were prepared with Statistical Analysis Software (SAS) release 9.3 
(SAS Institute, Cary, NC). All analyses were performed with R version 3.1.2 (R Foundation 
for Statistical Computing). The survey package was used to account for sampling weights and 
the psych package was used to perform principal component analysis. 
Results 
Characteristics of study participants are shown in Table 2, whereas means, standard 
deviations and frequencies of investigated nutrition and lifestyle factors are available in Table 
S1 (Supplementary Information).Using the ATP III definition for abdominal obesity, 55.6% 
of women and 28.8% of men were abdominally obese. Prevalence of other metabolic 
disorders was higher in both obese men and women compared to the non-obese counterparts.  
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We performed a systematic screening of the relationships of the 182 nutrition and lifestyle 
factors with abdominal obesity in men and women separately. A total of 30 factors with 
FDR<5% in men and 36 factors in women in the discovery set were examined for 
significance (P<0.05) in the replication set. In men, this resulted in 5 tentatively replicated 
factors showing significant inverse associations for serum α-carotene, -carotene, serum -
cryptoxanthin, serum vitamin D, and vigorous physical activity with abdominal obesity 
(Table 3). A total of 7 factors were replicated in women: serum vitamin C, serum α-carotene, 
-carotene, serum -cryptoxanthin, serum vitamin D, and vigorous physical activity were 
inversely correlated with abdominal obesity, whereas aspartame intake was positively 
associated with abdominal obesity. Replicated findings did not alter when we performed a 
sensitivity analysis including only factors with FDR<1% in the discovery survey or when we 
used the alternative categorisation of physical activity and smoking status (results not 
shown). Fig 2 depicts the distribution of P-values for each investigated factor and effect sizes 
(“Manhattan plot”). As seen in Fig 2, stronger associations between common factors and 
abdominal obesity were observed in women compared to men. Detailed results on 
associations between all factors and abdominal obesity are presented in the Supplementary 
Information (Table S2 and S3). 
 
Correlation between replicated factors is displayed as a heatmap in Fig S1 (Supplementary 
Information). To assess any structure underlying replicated nutrition and lifestyle factors, we 
performed a principal component factor analysis to identify common underlying factors. In 
men, two principal components (PC) were identified. The first PC mainly consisted of serum 
antioxidants (antioxidant PC). The second PC comprised serum vitamin D and vigorous 
physical activity (exercise-related PC). In addition to these two factors, a third factor (food 
additive PC) was identified in women, which only included aspartame intake. The total 
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variance of replicated variables explained by these principal components in men was 36% 
(95% CI: 34-36%) by antioxidant PC and 22% (21-22%) by exercise-related PC. In women, 
29% (95% CI: 29-31%) of total variance was explained by antioxidant PC, 16% (15-16%) by 
exercise-related PC, and 15% (14-15%) by food additive PC). 
 
For the final analysis, we obtained estimates for replicated nutrition and lifestyle factors in 
relation to abdominal obesity in the overall survey (phase I and phase II) for men and women 
(Table 4). In addition to these factors, we calculated estimates for antioxidant PC and 
exercise-related PC from the principal component analysis. We found that these two principal 
components were inversely associated with abdominal obesity in both sexes (Table 4). In a 
sensitivity analysis where we adjusted for BMI, only antioxidant PC was consistently 
associated with abdominal obesity in both men and women (Table S4). Associations remain 
significant for both principal components when models were adjusted for waist-to-hip ratio 
(Table S4). 
 
When we adjusted for other metabolic disorders as denoted by presence of one or more 
components of metabolic syndrome apart from obesity, the results were not altered, and all 
replicated factors remained significantly associated to abdominal obesity in men and women 
(Table 4). In a multivariable model incorporating all replicated factors, a lack of statistically 
significant association with abdominal obesity was observed for serum α-carotene in men and 
women, and for -cryptoxanthin in women. Other factors and all principal components 
identified remained significantly associated with abdominal obesity. The total variance 
explained by the multivariable model including replicated nutrition and lifestyle factors was 
11% and 17% for men and women, respectively. The total variance explained by replicated 
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factors was 2% and 6% in men and women, respectively. Similar contribution to variance 
was found for principal components in the multivariable models 
Discussion 
In a systematic screening of 182 nutrition and lifestyle factors, 5 factors in men and 7 factors 
in women were found to have statistically significant associations with abdominal obesity 
after applying the EWAS methodology among a representative sample of the U.S. 
population. Based on inter-correlation between these factors, three underlying principal 
components were identified. Lower odds of being abdominally obese were seen with higher 
quantities of factors representing serum antioxidants and exercise in both men and women, 
whereas a positive association was observed for aspartame intake in women, but not men.  
 
Circulating levels of common antioxidants including vitamin A metabolites and vitamin C 
have been reported to be inversely associated with general and abdominal obesity [31–35]. 
Recently, using repeated measurements, longitudinal associations between levels of these 
antioxidants and adiposity indicators were observed in postmenopausal women, indicating 
lower serum -carotene and higher γ-tocopherol  to be associated with higher WC [36]. 
However, results from clinical studies have failed to demonstrate benefit of antioxidant 
supplementation in prevention of obesity-related diseases such as cardiovascular disease [37] 
and breast cancer [38], although confounding by fruit and vegetable consumption may be 
implicated. Interestingly, a meta-analysis assessing a total of 78 randomised trials showed 
increased mortality with supplementation of -carotene or vitamin E, and with higher doses 
of vitamin A [39]. Our findings support inverse associations between serum antioxidants and 
abdominal obesity which was robust against variation in BMI and waist-to-hip ratio. The 
contrasting positive association between vitamin A levels and abdominal obesity, albeit not 
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seen in the replication set, may underline the discrepancy between absorbed pro-vitamin A 
and the tightly regulated levels of vitamin A [40,41]. In line with this, different associations 
between carotenoids and vitamin A levels with respect to other health outcomes such as 
mortality have also been noted [42]. Our findings also showed disagreement between dietary 
intake and serum levels of antioxidants in relation to obesity. Nevertheless, it is possible that 
this discrepancy and the lack of associations for dietary antioxidants that we observed was 
due to a lack of precision from measurement error and within-individual variation because 
information was obtained by a single 24-hour dietary recall. Alternatively, such discrepancy 
may also indicate the implication of physiological regulators of antioxidant metabolism rather 
than antioxidant intake on obesity and relevant health outcomes. In support of this, 
experimental evidence indicated that circulating carotenoids reduce adiposity through 
regulation of adipocyte thermogenesis [43]. These findings may indicate an interplay between 
antioxidant metabolism and physiological regulation of adiposity warranting further 
investigations. 
 
The role of physical activity in management of obesity has been well-established [44], as well 
as their opposing effects on health outcomes such as cardiovascular death [45]. Similarly, 
decreased levels of serum vitamin D among individuals with general and abdominal obesity 
have been reported [46–48] but the directionality of this association is unclear. Findings from 
a meta-analysis of vitamin D supplementation [49] and a Mendelian randomisation study [50] 
suggested that levels of vitamin D decrease secondary to increasing adiposity. Our study 
corroborates the inverse relationship between physical activity or serum vitamin D and 
abdominal obesity in both men and women. Additionally, from the principal component 
analysis, we observed a high correlation between physical activity and serum vitamin D. 
Although higher levels of physical activity have been linked to increasing levels of vitamin D 
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[51,52], their mechanistic association is unclear. Adding to the current evidence, we 
identified from the principal component analysis that an unobserved PC, which we denoted as 
„exercise-related‟, drove the associations of physical activity and serum vitamin D with 
abdominal obesity. One possible explanation is that levels of vitamin D may be a proxy for a 
healthier lifestyle which involves outdoor activities. However, it was suggested that sun 
exposure and time spent outdoor do not explain the majority of variation in vitamin D levels 
[53]. On the other hand, the notion that obesity is followed by decreasing vitamin D levels 
[49,50] may indicate a physical activity-obesity-vitamin D regulation axis. Mechanistic 
investigations are needed to confirm these plausible pathways.   
 
Aspartame is a methyl ester of a dipeptide and widely used as a synthetic non-nutritive 
sweetener (NNS) [54]. There is evidence that NNSs may interfere glucose and insulin 
response by disrupting learned physiological response [55,56]. However, a position statement 
by the Academy of Nutrition and Dietetics concluded that aspartame consumption was not 
associated with adverse health effects in humans (Grade I evidence) [57].  In the context of 
obesity, weight loss and maintenance among obese women have been reported following diet 
regimens incorporating aspartame-sweetened food and beverages, which are often part of 
diet-related products such as diet soda, compared to those without [58]. Nevertheless, there is 
a lack of evidence apart from clinical trials including individuals on weight management 
programmes. We found that higher aspartame intake correlated to more prevalent abdominal 
obesity in obese women. Although any obesogenic effect of aspartame intake has not been 
well-documented, our findings are in line with previous studies suggesting higher risks of 
subsequent general and abdominal obesity following use of artificially-sweetened beverages 
[59–61]. On the other hand, the positive association observed between aspartame intake and 
abdominal obesity in women may also signify certain behavioural patterns secondary to 
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obesity, such as efforts to moderate energy intake [56] and a „licensing effect‟, since artificial 
sweeteners are often a part of diets based on calorie restriction. The latter refers to 
disinhibition or „licensing‟ of unhealthy behaviours following commitment to a self-
perceived healthy behaviour [62,63], a phenomenon increasingly recognised in marketing 
research and experimental human studies. Further studies are needed to rule out such reverse 
causality, which is important in clarifying the role of aspartame in obesity and obesity-related 
outcomes. 
 
One of the strengths of this study is its generalisability following the use of nationally 
representative data of the U.S. population. We were able to adjust for major confounders such 
as education and PIR in our analysis. To our knowledge, this is the first study applying 
GWAS-like analytical approaches in studying determinants of obesity. Robustness of the 
statistical associations between investigated markers and obesity was ascertained through 
replication analysis and adjustment for presence of other metabolic factors. The systematic 
screening was able to eliminate factors with small effects which may be more prone to bias. 
Additionally, this method overcomes the limitation of selective reporting, which may be an 
issue with studies focusing on individual exposures. Nevertheless, it is important to address 
limitations of this study. NHANES III was set up as a cross-sectional study, thus our analysis 
was unable to identify any causality. Some nutrition and lifestyle factors were only measured 
in small numbers of the participants and this may have limited statistical power of the 
analysis. Many of investigated factors, such as smoking status and dietary assessment, were 
self-reported. For dietary assessment, only one 24-hour dietary recall was used. Such 
imprecision arising from subjective instruments and potential recall bias [64] may have 
resulted in the discrepancy between findings from dietary intake and serum levels of 
antioxidants. Therefore, it is necessary to confirm these results with objective measurements 
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such as digitalised instruments to monitor energy balance [65]. Nevertheless, these results 
may also indicate a role of physiological factors involved in oxidative stress response 
pathways, which may have greater influence than dietary intake of antioxidants in 
determining their serum levels. Definition of other metabolic disorders was limited by data 
availability in NHANES III. For instance, diabetes was based on fasting glucose and not all 
participants were fasting at time of measurements. Although we took into account potential 
confounders and inter-correlation between replicated factors, residual confounding may have 
occurred. It should also be noted that there were non-replicated factors in this study such as 
fat intake and serum cotinine that were individually correlated to abdominal obesity but did 
not display FDR<5% or significance in the replication set. Similarly, the association between 
aspartame intake and abdominal obesity may not have been gender-specific given a similar 
but weaker estimate in men after adjustment for multiple comparisons. These factors may still 
be associated, albeit weakly, with abdominal obesity. Furthermore, we were unable to 
exclude the potential role of other relevant factors apart from those assessed in NHANES III. 
Therefore, obtaining an equivalent definition of „genome-wide significance‟ as one would be 
able to claim in a GWAS analysis may be impractical or otherwise requires more rigorous 
and thorough assessments of nutrition and lifestyle determinants. 
Conclusion 
Using a comprehensive screening, our study identified nutrition and lifestyle factors 
demonstrating robust associations with abdominal obesity. Future mechanistic investigations 
are necessary in order to draw conclusions which may lead to development of suitable 
behavioural intervention and public policies aimed to reduce the obesity pandemic. 
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Table 1.Number and examples of nutrition and lifestyle factors in NHANES III 
Factor category No Examples 
Nutrition   
Food nutrient recall 104 Dietary fibre (continuous) 
  Aspartame (continuous) 
  Energy from protein (continuous) 
Healthy Eating Index (HEI) 10 Total HEI score (continuous) 
Nutrients and minerals (serum and 
urine) 
17 Serum vitamin A (continuous) 
  Serum selenium (continuous) 
Alcohol use 1 Drink alcohol twice or more a day (yes/no) 
Caffeinated beverages 1 Drink caffeinated beverages twice or more a day 
(yes/no) 
Lifestyle factors   
Personal smoking 14 Current smoker (reference: never smoker) 
  Ever smoked 20 cigars in life (yes/no) 
  Serum cotinine (continuous) 
Environmental smoking 4 Does anyone smoke in the home (yes/no) 
  At work, hours per day can smell smoking 
(ordinal) 
Physical activity 1 Vigorous physical activity (yes/no) 
Social support 2 How many times talking on the phone with 
family, friends or neighbours per week (ordinal) 
Environmental pollutants (serum 
and urine) 
2 Serum lead (continuous) 
  Urine cadmium (continuous) 
Bacterial infection 2 Helicobacter pylory antibody (continuous) 
Viral infection 8 Herpes Simplex Virus I antibody 
(positive/negative) 
  Hepatitis A antibody (positive/negative) 
Parasite infection 1 Toxoplasma antibody (continuous) 
Painkiller use 6 Taken aspirin in the past month (yes/no) 
  # NSAIDs taken in the past month (ordinal) 
External hormone use (females) 9 Age first taking birth control pills (ordinal) 
  Ever taken estrogen or female hormone pills 
other than birth control pills 
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Table 2. Descriptive characteristics of study participants 
 
 
Characteristic 
Weighted mean or proportion 
Men Women 
 Not obese 
(N=5,272) 
Obese 
(N=2,131) 
Not obese 
(N=3,694) 
Obese 
(N=4,634) 
Age – mean (SE) 40.48 (0.45) 50.60 (0.53) 40.18 (0.58) 50.08 (0.54) 
Race (%)     
Non-Hispanic white 74.65 81.84 78.75 72.95 
Non-Hispanic black 10.84 7.73 89.57 14.44 
Mexican-American 5.97 4.64 3.75 5.81 
Others 8.54 5.79 8.54 6.80 
Education (%)     
Less than high school 9.91 14.83 7.67 14.30 
High school equivalent 43.59 47.59 44.47 54.94 
Higher than high school 46.49 37.58 47.86 30.76 
Poverty-to-income ratio (PIR) (%)     
<1 11.09 9.52 11.25 17.61 
1-2 19.88 19.93 20.06 24.09 
2-3 20.61 24.57 20.37 20.59 
≥3 48.42 45.76 48.32 37.70 
Body mass index (kg/m
2
) – mean (SE) 24.53 (0.08) 31.87 (0.14) 22.38 (0.07) 31.17 (0.21) 
Metabolic disorder (%)     
Hypertension  15.01 36.61 8.86 25.97 
Diabetes 8.05 20.30 3.10 15.78 
Low HDL-cholesterol 27.21 49.78 26.84 47.77 
Triglyceridaemia 27.89 55.88 12.22 39.39 
©    2016 Macmillan Publishers Limited. All rights reserved.
2 
 
 
©    2016 Macmillan Publishers Limited. All rights reserved.
Table 3. Associations between replicated nutrition and lifestyle factors in relation to abdominal obesity in discovery and validation datasets. All 
models were adjusted for age, race/ethnicity, education, and PIR. Benjamini-Hochberg adjusted P-values for FDR<5% are presented for the 
discovery survey, and P-values from significance testing are presented for replication survey. 
 
 Discovery survey (Phase I) Replication survey (Phase II) 
Factors N obese/ 
N total 
OR (95% CI) P-value N obese/ 
N total 
OR (95% CI) P-value 
Men         
Serum α-carotene 1044 3673 0.61 (0.52-0.74) 0.002 1012 3389 0.63 (0.47-0.83) 0.005 
Serum -carotene 1044 3673 0.53 (0.40-0.70) 0.01 1012 3389 0.66 (0.46-0.94) 0.03 
Serum -cryptoxanthin 1044 3673 0.72 (0.61-0.84) 0.02 1012 3389 0.69 (0.58-0.82) 0.0004 
Serum vitamin D 1057 3712 0.85 (0.62-0.78) 0.001 1016 3413 0.84 (0.73-0.96) 0.02 
Vigorous physical activity 1098 3916 0.44 (0.31-0.64) 0.02 1033 3487 0.53 (0.35-0.82) 0.009 
Women         
Serum vitamin C 1887 3468 0.80 (0.72-0.89) 0.01 2389 4215 0.74 (0.65-0.84) 0.0002 
Serum α-carotene 1923 3534 0.65 (0.54-0.80) 0.02 2467 4355 0.66 (0.56-0.78) 0.0001 
Serum -carotene 1923 3534 0.60 (0.50-0.73) 0.003 2467 4355 0.58 (0.46-0.73) 0.0002 
Serum -cryptoxanthin 1923 3534 0.76 (0.65-0.89) 0.04 2467 4355 0.74 (0.64-0.83) 0.0001 
Serum vitamin D 1941 3567 0.63 (0.54-0.73) 0.003 2501 4401 0.72 (0.65-0.80) <0.0001 
Vigorous physical activity 2083 3827 0.40 (0.28-0.56) 0.003 2551 4501 0.62 (0.40-0.97) 0.04 
Aspartame intake 2028 3732 1.25 (1.15-1.37) 0.003 2481 4364 1.13 (1.01-1.26) 0.03 
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Table 4. Associations between replicated nutrition and lifestyle factors, identified principal components (PC), and abdominal obesity in overall 
study population  
 
N obese/N total
 OR (95% CI) 
 Model 1
a 
Model 2
a,b
 Model 3
a,c 
Model 4
a,c
 
Men       
Serum α-carotene 2056 7062 0.63 (0.52-0.75) 0.69 (0.58-0.82) 0.98 (0.96-1.01) - 
Serum -carotene 2056 7062 0.61 (0.47-0.78) 0.68 (0.56-0.85) 0.96 (0.94-0.99) - 
Serum -cryptoxanthin 2056 7062 0.71 (0.62-0.81) 0.73 (0.65-0.83) 0.97 (0.95-0.99) - 
Antioxidant PC
d 
2056 7062 0.76 (0.70-0.82) 0.79 (0.74-0.86) - 0.97 (0.96-0.98) 
Serum vitamin D 2073 7125 0.78 (0.69-0.89) 0.80 (0.71-0.91) 0.96 (0.94-0.98) - 
Vigorous physical activity
 
2131 7403 0.49 (0.36-0.68) 0.56 (0.41-0.76) 0.91 (0.86-0.97) - 
Exercise-related PC
d
 2073 7125 0.68 (0.59-0.79) 0.73 (0.63-0.83) - 0.94 (0.92-0.96) 
McFadden R
2
 full model     0.11 0.11 
McFadden R
2
 reduced model
e 
    0.02 0.02 
Women       
Serum vitamin C 4276 7683 0.77 (0.71-0.84) 0.82 (0.76-0.89) 0.98 (0.96-0.99) - 
Serum α-carotene 4389 7888 0.66 (0.58-0.75) 0.73 (0.65-0.82) 0.99 (0.97-1.01) - 
Serum -carotene 4389 7888 0.59 (0.52-0.67) 0.66 (0.58-0.74) 0.94 (0.92-0.96) - 
Serum -cryptoxanthin 4389 7888 0.75 (0.67-0.84) 0.79 (0.72-0.87) 0.99 (0.97-1.02) - 
Antioxidant PC
d 
4266 7660 0.79 (0.74-0.82) 0.82 (0.78-0.87) - 0.96 (0.95-0.97) 
Serum vitamin D 4442 7968 0.68 (0.62-0.74) 0.67 (0.62-0.73) 0.94 (0.92-0.95) - 
Vigorous physical activity 4634 8328 0.50 (0.38-0.66) 0.48 (0.36-0.65) 0.90 (0.85-0.96) - 
Exercise-related PC
d 
4442 7968 0.56 (0.50-0.63) 0.56 (0.49-0.62) - 0.91 (0.89-0.93) 
Aspartame intake 4509 8096 1.18 (1.10-1.26) 1.16 (1.08-1.24) 1.04 (1.02-1.06) 1.04 (1.02-1.05) 
McFadden R
2 
full model     0.19 0.17 
McFadden R
2
 reduced model
e 
    0.07 0.06 
a
Adjusted for age (continuous), race/ethnicity, education, PIR 
b
Adjusted for presence (yes, no) of other components of metabolic syndrome: hypertension, diabetes, low HDL, hypertrigliceridaemia 
c
All variables were included in the same model 
d
Extracted from principal component analysis 
e
Not adjusted for age (continuous), race/ethnicity, education, PIR 
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